MGI Tech
MGI Tech, Predica Diagnostics Partner to Develop RNA-Based Cancer Screening Tests
The companies will combine Predica’s proprietary circular probe-based RNA-seq technology with MGI’s DNBSeq platforms for early cancer detection.
Dinfectome Nabs China NMPA Approval for Benchtop NGS Sequencer
The Chinese molecular diagnostics firm said the DIFSeq-200 platform can achieve a Q30 score of above 85 percent while generating multiple read lengths.
NgeneBio Partners With MGI Tech on Precision Cancer Diagnostics
The South Korean NGS diagnostic firm will combine its cancer diagnostic tests with MGI’s DNBSeq-G99 sequencer to expand its global commercial presence.
Invivoscribe, Complete Genomics Partner to Develop, Commercialize Oncology Biomarker Tests
The companies will collaborate to develop biomarkers tests for minimal residual disease (MRDs) in research and clinical setting using the DNBSeq sequencer.
MGI Tech Gets CE Mark for DNBSeq-G99 Sequencer Under New EU IVDR Framework
The CE mark allows the Chinese NGS instrument maker to roll out its new platform in the EU and other countries that accept the designation.